ClinicalTrials.govpublic full text
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease
liver cancer, neuroendocrine tumors, net, liver dominant disease, therasphere, yttrium-90, y-90, everolimus, afinitor, zortress, rad001, microspheres
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1032192
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.